Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts
CompletedOBSERVATIONAL
Enrollment
233
Participants
Timeline
Start Date
January 15, 2021
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
Conditions
Asthma
Trial Locations (2)
48109
University of Michigan, Ann Arbor
80206
National Jewish Health, Denver
All Listed Sponsors
lead
University of Michigan
OTHER
NCT06922760 - Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts | Biotech Hunter | Biotech Hunter